Wang, Guochang
Hong, Haiyan
Zang, Jie
Liu, Qingxing
Jiang, Yuanyuan
Fan, Xinrong
Zhu, Zhaohui
Zhu, Lin
Kung, Hank F.
Article History
Received: 21 July 2021
Accepted: 23 August 2021
First Online: 23 September 2021
Declarations
:
: Ethical approval was obtained from the Institute Review Board of Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, and this study was conducted in accordance with the principles of the Declaration of Helsinki.
: Informed consent was obtained from all participants included in the study.
: Hank F. Kung is the founder of Five Eleven Pharma, which holds the patent rights for [<sup>68</sup> Ga]Ga-P16-093 and related technology.